1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morooka, S; Natsume, Y | 1 |
| Huber, M; Keppler, D | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Experimental Hepatoma
| Article | Year |
|---|---|
Effect of SM-12502 on disseminated intravascular coagulation (DIC) in tumor-bearing rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disseminated Intravascular Coagulation; Injections, Intravenous; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Platelet Activating Factor; Rats; Rats, Wistar; Thiazoles; Thiazolidines; Time Factors; Tumor Cells, Cultured | 1996 |
Inhibition of leukotriene D4 catabolism by D-penicillamine.
Topics: Animals; Bile; Dipeptidases; Kinetics; Liver Neoplasms, Experimental; Penicillamine; Platelet Activating Factor; Rats; SRS-A | 1987 |